Search
IVTEAM

Outpatient parenteral antimicrobial therapy uncompensated provider time

"In this study of a large academic OPAT program, the median amount of unbilled OPAT management time was 27 minutes per week, per OPAT course" Schranz et al (2024).

"In this study of a large academic OPAT program, the median amount of unbilled OPAT management time was 27 minutes per week, per OPAT course" Schranz et al (2024).

ReTweet

Outpatient parenteral antimicrobial therapy uncompensated provider time

Abstract:

Outpatient parenteral antimicrobial therapy (OPAT) relies on substantial uncompensated provider time. In this study of a large academic OPAT program, the median amount of unbilled OPAT management time was 27 minutes per week, per OPAT course. These data should inform benchmarks in pursuing novel payment approaches for OPAT.


Reference:

Schranz AJ, Swartwood M, Ponder M, Boerneke R, Oosterwyk T, Perhac A, Farel CE, Kinlaw AC. Quantifying the Time to Administer Outpatient Parenteral Antimicrobial Therapy: A Missed Opportunity to Compensate for the Value of Infectious Diseases. Clin Infect Dis. 2024 May 14:ciae262. doi: 10.1093/cid/ciae262. Epub ahead of print. PMID: 38743581.

Facebook Twitter Linkedin Rss Envelope

About IVTEAM citation library

IVTEAM has established itself as a core global resource for infusion and vascular access practitioners. Each day 6K users have access thousands of pages of easy to access relevant intravenous news and updates. IVTEAM offers its visitors a premier service that has no financial or subscriber based restrictions. The editorial stance of IVTEAM is to ensure no editorial restrictions exist; content remains unbiased and independent.

It is crucial that IVTEAM stays up-to-date and offers visitors regular, current updates. Each day news feeds are analysed, websites searched and various additional sources of information visited. This results in large amounts of data being sifted through for relevant information every day. Only a small amount of data is relevant to IV practice and makes it onto IVTEAM.

Read more
Copyright 2024 © IVTEAM. All rights Reserved.